123 related articles for article (PubMed ID: 8743062)
21. Use of a database computer program to identify trends in reporting of adverse drug reactions.
Johnston PE; Morrow JD; Branch RA
Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
[TBL] [Abstract][Full Text] [Related]
22. Pharmacist-managed monitoring of adverse reactions to contrast media.
Damiani DR; Swanson DP
Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
[TBL] [Abstract][Full Text] [Related]
23. Reporting adverse drug reactions is everyone's business: an adverse drug reaction reporting program that works.
Burkhardt ME; Ripepe SD
Top Hosp Pharm Manage; 1992 Jul; 12(2):31-9. PubMed ID: 10128727
[TBL] [Abstract][Full Text] [Related]
24. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
Zimmermann A; Gaworska-Krzeminska A; Flis A
Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
[TBL] [Abstract][Full Text] [Related]
25. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
[TBL] [Abstract][Full Text] [Related]
26. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
27. Use of standardized screening procedures to identify adverse drug reactions.
Koch KE
Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
[TBL] [Abstract][Full Text] [Related]
28. Pharmacy Student Facilitation of Reporting of Adverse Drug Reactions in a Hospital.
Wentzell J; Nguyen T; Bui S; MacDonald E
Can J Hosp Pharm; 2017; 70(4):276-280. PubMed ID: 28894311
[TBL] [Abstract][Full Text] [Related]
29. Monitoring adverse drug reactions across a nationwide health care system using information technology.
Emmendorfer T; Glassman PA; Moore V; Leadholm TC; Good CB; Cunningham F
Am J Health Syst Pharm; 2012 Feb; 69(4):321-8. PubMed ID: 22302257
[TBL] [Abstract][Full Text] [Related]
30. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
31. Feasibility study of surveying the adverse drug reaction surveillance systems in a large community of hospitals.
Herrera CR; Moss JT; Reves RR; Buffler PA
Ann Pharmacother; 1992 Mar; 26(3):384-91. PubMed ID: 1554961
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
33. Multidisciplinary adverse drug reaction surveillance program.
Prosser TR; Kamysz PL
Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
[TBL] [Abstract][Full Text] [Related]
34. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
Bond CA; Raehl CL
Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
[TBL] [Abstract][Full Text] [Related]
36. The role of hospital and community pharmacists in pharmacovigilance.
van Grootheest AC; de Jong-van den Berg LT
Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
Sunara P; Krnic D; Puljak L
Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
[TBL] [Abstract][Full Text] [Related]
38. Awareness and reporting of adverse drug reactions among health care professionals in Sudan.
Elnour AA; Ahmed AD; Yousif MA; Shehab A
Jt Comm J Qual Patient Saf; 2009 Jun; 35(6):324-9. PubMed ID: 19565692
[TBL] [Abstract][Full Text] [Related]
39. The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reporting.
Shchory MP; Goldstein LH; Arcavi L; Shihmanter R; Berkovitch M; Levy A
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1246-1253. PubMed ID: 32316074
[TBL] [Abstract][Full Text] [Related]
40. The spontaneous reporting of adverse drug reactions by nurses.
Hall M; McCormack P; Arthurs N; Feely J
Br J Clin Pharmacol; 1995 Aug; 40(2):173-5. PubMed ID: 8562303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
